Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous fentanyl versus lidocaine for attenuation of hemodynamic response to laryngoscopy and endotracheal intubation
PACTR202001700384281Phase 4Completed
- Sponsor
- Dilla University
- Start
- Jul 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fentanyl and lidocaine (2 arms), sponsored by Dilla University. Primary endpoint: Change in hemodynamic status from baseline. Started Jul 2018; status: completed.
02
Drugs
fentanyllidocaine
Beyond the preview
Go deeper on PACTR202001700384281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001700384281.